Kitasato Research Center for Environmental Science; Japan
Objective
To evaluate the efficacy of the 7000 series and the Plasma BAR in reducing Influenza A (H1N1) virus.
Methodology
The 0.2 m3 acrylic test chamber was put into biological safety cabinet. The D5 device and fan were then placed in the test chamber. The virus suspensions were sprayed into the chamber using a compressor-type nebulizer NE-C16 (OMRON) into the test chamber for 5 minutes at an air flow ratio of approximately 0.2 mL/min.
Summary of Results
The device reduced 86.6% of Influenza A virus after one hour.
USA Headquarters
Stamford, Connecticut
Call: 1 866 508 1118 Email: info@wellairsolutions.com
Ireland Headquarters
DCU Innovation Campus Old Finglas Road Glasnevin, Dublin 11
Call: +353 1 907 2750 Email: info@wellairsolutions.com